Genetic mutation could worsen heart function in Duchenne muscular dystrophy patients
(UT Southwestern Medical Center) DALLAS - Nov. 4, 2020 - A mutation in the gene that causes cystic fibrosis may accelerate heart function decline in those with Duchenne muscular dystrophy (DMD), a new study by UT Southwestern researchers suggests. The findings, published online recently in theJournal of the American Heart Association, could help doctors develop new strategies to preserve heart function in this population, potentially extending patients' lives. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 4, 2020 Category: International Medicine & Public Health Source Type: news
FDA Approves Bronchitol (mannitol) Inhalation Powder to Improve Pulmonary Function in Adult Patients with Cystic Fibrosis
CARY, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), received U.S. Food and Drug Administration (FDA) approval of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 2, 2020 Category: Drugs & Pharmacology Source Type: news
Let's (not) stick together
(University of Pittsburgh) New research led by the University of Pittsburgh's Swanson School of Engineering examines the properties of the mucus of cystic fibrosis (CF) patients and the role it plays in a pathogens' ability to survive. The new information could have important implications for CF treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 28, 2020 Category: International Medicine & Public Health Source Type: news
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Appointment adds extensive expertise in the development of anti-infectives, including bacteriophage therapy to treat P. aeruginosa infections in cystic fibrosis patients
MARINA DEL REY, Calif., Oct. 26, 2020 -- (Healthcare Sales & Marketing Network) --... Biopharmaceuticals, Personnel Armata Pharmaceuticals, bacteriophage therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 26, 2020 Category: Pharmaceuticals Source Type: news
Twin left fighting for his life with cystic fibrosis has finally got £28,000 drug that will save him
Anthony Usher, from Liverpool, has cystic fibrosis, an incurable genetic condition that destroys the lungs and digestive system. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2020 Category: Consumer Health News Source Type: news
Researchers create human airway stem cells from patients' cells
(Boston Medical Center) For the first time, researchers have successfully created airway basal stem cells in vitro from induced pluripotent stem cells by reprogramming blood cells taken from patients. Given that airway basal cells are defined as stem cells of the airways because they can regenerate the airway epithelium in response to injury, this study may help accelerate research on diseases impacting the airway, including COVID-19, influenza, asthma and cystic fibrosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2020 Category: International Medicine & Public Health Source Type: news
Thirona obtains AI software patent for treatment of cystic fibrosis in children
The AI company will use the license to implement a quantitative method for the analysis of chest CT scans. (Source: mobihealthnews)
Source: mobihealthnews - October 16, 2020 Category: Information Technology Source Type: news
Cystic fibrosis latest: New wonder drug Kaftrio gives hope to sufferers
Cystic fibrosis wonder drug Kaftrio is now being rolled out across the UK and today the Daily Express brings you the stories of renewed hope as sufferers reveal how it will transform their lives. (Source: Daily Express - Health)
Source: Daily Express - Health - October 11, 2020 Category: Consumer Health News Source Type: news
IV, Oral Antibiotics Comparable for Treating P. aeruginosa in CF
Results do not support use of IV antibiotics to eradicate P. aeruginosa in cystic fibrosis, authors say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 8, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
IV, Oral Antibiotics Comparable for Treating P. aeruginosa in CF
THURSDAY, Oct. 8, 2020 -- Intravenous antibiotics do not achieve greater sustained eradication of Pseudomonas aeruginosa in patients with cystic fibrosis compared with oral therapy, according to a study published in the October issue of The Lancet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 8, 2020 Category: Pharmaceuticals Source Type: news
Treating cystic fibrosis with mRNA therapy or CRISPR
(Mary Ann Liebert, Inc./Genetic Engineering News) The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 8, 2020 Category: International Medicine & Public Health Source Type: news
COVID-19 rapid guideline: cystic fibrosis [NG170], NICE (updated 7th October 2020)
On 7 October 2020, we withdrew our recommendations on reducing or deprioritising cystic fibrosis registry data entry, limiting transplant services and deferring transition to adult services because these emergency measures are no longer needed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 7, 2020 Category: Consumer Health News Source Type: news
DDT COA #000007: The Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)
Clinical Outcome Assessments (COA) Qualification Submissions
Office of Antimicrobial Products (OAP)
Division of Anti-Infective Products (DAIP)
DDT COA Number
DDT COA #000007 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 7, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Thirona licenses patent for cystic fibrosis AI software
Dutch artificial intelligence (AI) software developer Thirona said it has exclusively...Read more on AuntMinnie.comRelated Reading:
Thirona, Smart Reporting team up on COVID-19 software
Free AI software can help triage COVID-19 on x-ray
Thirona unveils AI software for COVID-19 analysis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 6, 2020 Category: Radiology Source Type: news
Can You Live A Long Life with Cystic Fibrosis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 30, 2020 Category: General Medicine Source Type: news
